Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Retatrutide is an unapproved investigational triple agonist (GLP-1, GIP, glucagon receptors) not licensed by the MHRA, EMA, or FDA for routine clinical use
Rotating injection sites helps minimize this
The total daily dose typically does not exceed 0.50 mg to 0.75 mg, as higher amounts have not demonstrated proportionally greater benefits in available research
Though generally safe, following the recommended dosage guidelines is crucial for avoiding potential negative side consequences
US$ 26.39
US$ 26.82
US$ 22.85
US$ 24.67
US$ 23.24
US$ 20.82
US$ 26.04
US$ 21.12
US$ 24.94
US$ 21.14
US$ 23.61
